Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Sonoma Pharmaceuticals (SNOA) Net Cash Flow (2016 - 2025)

Sonoma Pharmaceuticals has reported Net Cash Flow over the past 16 years, most recently at -$601000.0 for Q4 2025.

For Q4 2025, Net Cash Flow fell 147.29% year-over-year to -$601000.0; the TTM value through Dec 2025 reached -$3.4 million, down 195.3%, while the annual FY2025 figure was $2.9 million, 495.3% up from the prior year.
Net Cash Flow for Q4 2025 was -$601000.0 at Sonoma Pharmaceuticals, up from -$707000.0 in the prior quarter.
Over five years, Net Cash Flow peaked at $5.6 million in Q3 2021 and troughed at -$2.2 million in Q3 2022.
A 5-year average of -$171600.0 and a median of -$484000.0 in 2023 define the central range for Net Cash Flow.
On a YoY basis, Net Cash Flow climbed as much as 2623.32% in 2021 and fell as far as 1460.67% in 2021.
Year by year, Net Cash Flow stood at $137000.0 in 2021, then tumbled by 561.31% to -$632000.0 in 2022, then soared by 133.7% to $213000.0 in 2023, then surged by 496.71% to $1.3 million in 2024, then tumbled by 147.29% to -$601000.0 in 2025.
Business Quant data shows Net Cash Flow for SNOA at -$601000.0 in Q4 2025, -$707000.0 in Q3 2025, and -$2.2 million in Q2 2025.